Routine insider initial filing. Monitor future Form 4 filings for any open-market purchases by the CFO, which could signal conviction. No immediate trading action warranted.
Price Chart
Executive Summary
Julie Feder filed a Form 3 initial statement of beneficial ownership as the new Chief Financial Officer of Obsidian Therapeutics. The filing discloses only stock option grants (exercise price $0.78) with standard vesting schedules; no direct share ownership is reported. This is a routine administrative filing with no material trading or financial information.
Key Facts
- Julie Feder appointed as CFO at Obsidian Therapeutics, Inc.
- Holds options to buy 2,732,337 shares at $0.78, vesting 25% on Jan 12, 2027, then quarterly.
- Holds options to buy 271,604 shares at $0.78, vesting 50% on Sep 30, 2026, then quarterly.
- No direct ownership of common stock reported on Form 3.
Financial Impact
Standard CFO option grant — no immediate financial impact
Risk Factors
- No direct stock ownership indicates limited alignment with shareholders at this time.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-330998 |
| Document: 0001193125-26-330998-index-headers.html | 0001193125-26-330998 |
| Document: 0001193125-26-330998-index.html | 0001193125-26-330998 |
| Document: 0001193125-26-330998.txt | 0001193125-26-330998 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | SC 13G | $13.22 | awaiting T+20 | — | $13.60 (+2.84%) |
Sep 10, 2026 6w ago | EFFECT | $17.16 $12.24 | ▼ −28.67% | ▼ −30.80% | $13.60 (−20.78%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 3 | $34.00 $17.04 | ▼ −49.88% | ▼ −48.64% | $13.60 (−60.01%) |
Aug 3, 2026 12w ago | 8-K | $34.00 $17.04 | ▲ +49.88% | ▲ +48.64% | $13.60 (+60.01%) |
Jul 6, 2026 16w ago | EFFECT | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers